$CNMD Q3 '26 Earnings Results & Recap
• Reported GAAP EPS of $1.04 down -3.70% YoY
• Reported revenue of $335.56M down -0.70% YoY
• CONMED expects to repurchase approximately $62M in 2026 under its authorized share repurchase program; no quantified revenue, margin, or earnings outlook is provided in this filing.